Core Insights - Haisco has transformed from a specialized pharmaceutical company to an integrated innovative drug research, production, and sales group since its establishment in 2000, focusing on key therapeutic areas such as anesthesia, respiratory, and chronic diseases [1][2] - The company has developed a diversified pipeline of innovative drugs, with several projects like HSK31858 and HSK39297 in late-stage clinical development, and its first innovative drug,环泊酚, received FDA acceptance for listing in the U.S. in July 2025 [1][2] Financial Performance - In Q3 2025, Haisco achieved a revenue of 3.3 billion yuan, representing a year-on-year growth of 19.95% [1] - By the end of 2025, Haisco's market capitalization reached 57.5 billion yuan, ranking first in the Tibet region [1] Capital Operations - In February 2023, Haisco raised 800 million yuan through its first private placement to support the approval and inclusion of two innovative drugs,考格列汀片 and 苯磺酸克利加巴林胶囊, in the medical insurance system by 2024 [1] - The company has established a full-process technical system from early drug discovery to commercialization, enabling rapid product volume growth through academic marketing and channel integration [2] Investor Relations - Haisco has implemented a shareholder return plan for 2025-2027, committing to annual cash dividends of no less than 10% of the distributable profits or a cumulative cash dividend of no less than 30% of the average net profit over the last three years [2] - Since its listing, Haisco has distributed over 3.67 billion yuan in cash dividends, achieving a dynamic balance between corporate development and shareholder returns [2] Future Outlook - Haisco aims to continue focusing on the core innovative drug sector, leveraging its full-process R&D platform and capital operations to accelerate the implementation of ongoing projects and strengthen its international market presence [2]

Group 1 - The Shanghai Composite Index experienced a significant increase of 1.5%, achieving a record of 13 consecutive positive trading days, surpassing the previous record of 12 days set in 1992 [1] - Historical data indicates that instances of the Shanghai Composite Index achieving more than 10 consecutive positive days are rare, and the market's trajectory following such streaks is highly uncertain [1] - For example, during the 11 consecutive positive days from June 15 to June 29, 2006, the index rose by 9.16%, leading to a subsequent bull market where the index more than doubled [1] Group 2 - Yang Delong, Chief Economist at Qianhai Kaiyuan Fund, believes that the market in 2026 will continue the trends established in 2025, supported by factors such as policy support and positive foreign investment sentiment towards China's technological innovations [2] - The A-share market is expected to transition from a structural bull market to a comprehensive bull market in 2026, with potential valuation increases for previously underperforming leading stocks in sectors like consumption, new energy, military, and non-ferrous metals [2]

Group 1 - The core point of the news is the significant market movement in solid-state battery stocks, driven by the announcement of the world's first commercially viable all-solid-state battery by Finnish startup Donut Lab [1] - Solid-state batteries are expected to revolutionize the electric vehicle industry due to their superior energy density, charging speed, cycle life, and adaptability to extreme environments [1] - Aijian Securities believes that the industrialization of solid-state batteries is accelerating, with a high likelihood of using sulfide electrolytes and silicon/lithium metal anodes, which offer better mechanical properties and ionic conductivity [1] Group 2 - According to statistics, several companies have been highlighted in institutional research reports regarding solid-state batteries, including Tianci Materials, Haixi Communications, and Xiamen Tungsten New Energy [2] - Tianci Materials is in the pilot testing stage for sulfide electrolytes, focusing on performance advantages in moisture control and cycle efficiency, with plans to establish a hundred-ton pilot production line by mid-2026 [2] - Xiamen Tungsten New Energy has achieved supply of positive electrode materials for oxide route solid-state batteries and has successfully produced ton-level oxide solid electrolytes [2] Group 3 - Predictions indicate that several solid-state battery concept stocks, such as Enjie Co., Rongbai Technology, and Ganfeng Lithium, are expected to see a significant increase in net profits this year, with some companies projected to double their net profits [3] - Other companies like Tiannai Technology and EVE Energy are also expected to experience net profit growth exceeding 50% [3]

作为资本市场焦点赛道，商业航天板块近期涨势未减。2025年12月24日以来，万得商业航天主题指数实 现八连阳，累计涨幅超36%。 火箭发射次数创新高 据央视网报道，2025年我国在载人航天、深空探测、商业航天等领域完成多项突破，实现多个首次。 2025年，中国航天全年发射次数创历史新高，达到92次，发射次数较2024年全年增加超过三成，标志着 我国航天发射能力进入了"常态化、高频化、规模化"的新阶段。 资本市场上也传来了IPO的新消息。2025年12月31日，蓝箭航天科创板IPO获受理；电科蓝天科创板IPO 注册获同意。 展望2026年，业内人士普遍认为，在政策与技术双轮驱动下，中国商业航天预计将迎来火箭发射的"大 年"。 火箭可回收技术加速验证 作为商业航天产业链的上游，火箭回收复用不仅能大幅降低发射成本，还可以显著提升发射任务的响应 效率。 据集邦咨询数据，目前部分可回收火箭成本(报价)为6700万美元左右，随着全球主要大厂积极发展可回 收技术，在达成全面回收的情况下，有望将发射成本(报价)降低至200万至500万美元。 面对高成本、星多箭少的现状，可回收技术是国内商业火箭公司实现降本的必经之路，更是突破 ...

Group 1 - The joint statement from European leaders emphasizes that Arctic security is a key priority for Europe and is crucial for international and transatlantic security [1] - NATO has identified the Arctic region as a focus area, with European allies increasing their presence, activities, and investments in the region to maintain security and deter adversaries [1] - The statement asserts that Arctic security must be achieved within the NATO framework, in collaboration with allies including the United States, and based on principles of the UN Charter, including sovereignty and territorial integrity [1] Group 2 - The U.S. Special Envoy to Greenland stated that President Trump supports Greenland's independence [2]

多家公司表示，其脑机接口产品尚处早期培育阶段，且技术路线与国际主流有明显区别。 近期，脑机接口等概念股持续飙涨。截至1月6日，已有多只概念股连续三个交易日收盘价涨幅偏离值累计达到30%。对 此，多家上市公司1月6日晚发布股票交易异常波动公告，称在脑机接口领域的新产品仍处于市场培育初期，且与国际主 流存在显著技术路径差异。 其中，麦澜德在公告中称，截至目前，公司在脑机接口领域的产品尚处于研发及市场培育期，尚未实现规模化销售，暂 未对公司业绩产生重大影响。技术路线上，公司主要聚焦于非侵入式脑机接口技术的研发和产品化，与当前国际主流的 侵入式脑机接口存在显著技术路径差异。 伟思医疗在公告中也表示，公司主营业务聚焦于康复医疗器械的研发、生产与销售，产品广泛应用于精神康复、盆底及 产后康复、神经康复等领域。截至2025年末，公司在脑机接口领域的新产品仍处于市场培育初期，主要布局非侵入式技 术路线，与当前国际领先的侵入式脑机接口存在显著技术路径差异，相关产品尚未实现规模化销售，对整体营业收入的 贡献仍较为有限。 证券代码:688580 证券简称:伟思医疗 公告编号:2026-001 南京伟恩医疗科技股份有限公司 股票交易 ...

数据中心冷却股集体大跌。 当地时间周二，美股三大指数开盘涨跌互现，截至发稿，三大指数全线上涨，道琼斯指数涨0.15%，标普500指数涨0.31%，纳斯达克综合指数涨0.38%。 现货黄金涨0.80%，报4484.27美元/盎司；现货白银涨4.42%，报80.01美元/盎司。 （文章来源：证券时报） 黄仁勋强调，英伟达的核心使命是构建全栈AI平台，让每个企业、行业与国家都能参与AI革命。目前，英伟达已开放包括NeMo（大语言模型）、 BioNeMo（生物计算）、Clara NeMo（医疗AI）在内的全套工具链，提供从数据处理、模型训练到部署的全生命周期管理支持。同时，推出的"蓝图"框架 允许开发者轻松构建定制化AI助理，结合本地开放模型与前沿API，实现隐私保护与功能扩展的平衡。 芯片股普涨，微芯科技涨7.7%，达到自7月以来的最高水平，恩智浦、台积电涨超2%。闪迪（SanDisk）股价创盘中历史新高，最新上涨13％。 美光科技涨幅扩大至6.5%，报332美元/股，再创历史新高，总市值达到3700亿美元。 热门中概股多数上涨，纳斯达克中国金龙指数涨0.67%，蔚来、小鹏汽车、网易涨超1%，阿里巴巴跌超1%。 | ...

在美国芝商所两次上调保证金之后，黄金白银等贵金属大幅震荡下，仍然保持高位上冲姿态，铜、铝等 基本金属则在不断刷新历史高位。 在经过2025年超60%的涨幅后，投资机构对于2026年黄金涨幅趋向于谨慎，但是对于涨幅超146%的白 银仍然充满想象力。而国投白银LOF（161226）份额仍在创下历史高点。相对于贵金属而言，期货市场 资金更偏爱铜铝等基本金属，特别是铜在两个交易日资金大幅净流入。 白银比黄金还有想象空间 清和泉资本认为，2026年最大的投资机会之一，就是战略资源股，如铜、铝、煤等。当前这些上游品种 供需均处于平衡或紧缺的状态，中上游品种则依托中国成本优势，盈利水平处于历史高位，而且这些行 业均存在具备全球竞争力的企业，包括成本水平、管理水平等，其中铜的公司成长属性高一点，铝和煤 炭的价值属性更突出；这些行业中，估值低的品种PE在10倍左右，高的在15倍左右，中期性价比依然 十分可观。 1月6日，国内黄金主力2602合约收盘时，报价继续站上1000元/克关口上方。而白银主力2604合约，收 盘价格创下历史新高，报19452元/千克，涨幅7.06%，成交量和持仓量均大幅增长，其中成交量增加了 125.8万 ...

Core Viewpoint - The significant short-term stock price increases of Jiamei Packaging and Guosheng Technology have led to their suspension for verification starting January 7, 2026, with an expected duration of no more than three trading days [1][2]. Group 1: Jiamei Packaging - Jiamei Packaging's stock price surged by 230.48% from December 17, 2025, to January 6, 2026, achieving 11 limit-up days in 13 trading days, with a closing price of 15.07 yuan per share and a market capitalization exceeding 14 billion yuan [1]. - The stock price increase is attributed to a change in control, where the controlling shareholder, China Food Packaging Co., Ltd., plans to transfer 279 million shares (29.9% of total shares) to Suzhou Zhuyue Hongzhi Technology Development Partnership [1][2]. - Following the transfer, the new controlling entity will be Zhuyue Hongzhi, with Yu Hao, the founder and CEO of high-end technology brand Chasing Technology, becoming the actual controller [2]. Group 2: Guosheng Technology - Guosheng Technology's stock price rose by 370.2% from October 31, 2025, to January 6, 2026, with multiple instances of abnormal trading fluctuations [2][3]. - The surge is driven by news of cross-industry investments in the lithium battery sector, including a 230 million yuan capital increase for a solid-state battery manufacturing project and a planned acquisition of 100% of the shares of Copper City Fuyue Technology for 240 million yuan [3]. - Despite the stock price increase, Guosheng Technology's performance has been poor, with a revenue of 450 million yuan in the first three quarters of 2025, a year-on-year decline of 57.79%, and a net loss of 151 million yuan [3].

Core Viewpoint - The southbound funds' ETF trading volume today is 1.204 billion HKD, a decrease of 9.068 billion HKD from the previous day, accounting for 0.90% of the total southbound funds' trading volume today [1] Group 1: Trading Volume Breakdown - The trading volume for the Hong Kong Stock Connect (Shanghai) ETF is 0.872 billion HKD [1] - The trading volume for the Hong Kong Stock Connect (Shenzhen) ETF is 0.332 billion HKD [1] - The total trading volume for the Hong Kong Stock Connect is 1.204 billion HKD [1]